These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1504979)

  • 1. Efficacy of therapeutic interventions for silent myocardial ischemia and clinical trial benefit.
    Gottlieb SO
    Cardiol Clin; 1992 Aug; 10(3):479-86. PubMed ID: 1504979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of silent myocardial ischemia.
    Singh N; Langer A
    Can J Cardiol; 1995 Apr; 11(4):286-9. PubMed ID: 7728640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary management of silent ischemia: the role of ambulatory monitoring.
    Solomon H; DeBusk RF
    Int J Cardiol; 2004 Sep; 96(3):311-9. PubMed ID: 15301883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent myocardial ischemia. Rationale for management.
    Pepine CJ; Coy K; Lambert CR; Hill JA; Norvell N
    Postgrad Med; 1988 Feb; Spec No():76-82. PubMed ID: 2894663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical indications of ischemic heart disease: a physician's viewpoint].
    Haze K
    J Cardiol; 1988 Sep; 18(3):845-55. PubMed ID: 2977800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical considerations in the use of calcium entry blockers in silent myocardial ischemia.
    Crawford MH
    Circulation; 1989 Dec; 80(6 Suppl):IV74-7. PubMed ID: 2574641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silent myocardial ischaemia: to treat or not to treat?
    Barsotti A
    Eur Heart J; 1991 Dec; 12 Suppl G():8-15. PubMed ID: 1806382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revascularization procedures in the treatment of single-vessel coronary disease.
    Parisi AF; Burtt DM
    Coron Artery Dis; 1993 Dec; 4(12):1053-60. PubMed ID: 7909263
    [No Abstract]   [Full Text] [Related]  

  • 11. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination of anti-angina drugs].
    Silber S
    Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the optimal medical management of ischemic heart failure?
    Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M
    Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of diltiazem in the treatment of silent myocardial ischemia.
    Waters D; Juneau M; Baird M; Klinke P; Warnica W; Chin C; Théroux P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S15-20. PubMed ID: 1725537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of silent myocardial ischemia.
    Bleske BE; Shea MJ
    Clin Pharm; 1990 May; 9(5):339-57. PubMed ID: 1972045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Silent myocardial ischemia: 3 years' experience with Holter].
    de Pádua F; Fiuza M; Correia J
    Acta Med Port; 1990; 3(1):15-20. PubMed ID: 2333772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.